BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25499923)

  • 1. TLR4- and TLR9-dependent effects on cytokines, cell viability, and invasion in human bladder cancer cells.
    Olbert PJ; Kesch C; Henrici M; Subtil FS; Honacker A; Hegele A; Hofmann R; Hänze J
    Urol Oncol; 2015 Mar; 33(3):110.e19-27. PubMed ID: 25499923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on Toll-like receptors expression and cytokine production induced by bacillus Calmette-Guerin in human bladder cancer cell].
    Li X; Gong ZY; Li H; Wei Q; Shi M; Yang YR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):177-81. PubMed ID: 15062066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different Bacillus Calmette-Guerin substrains on growth inhibition of T24 bladder cancer cells and cytokines secretion by BCG activated peripheral blood mononuclear cells of PBMCs.
    Janaszek-Seydlitz W; Prygiel M; Bucholc B; Wiatrzyk A; Czajka U; Górska P; Soliwoda U
    Adv Clin Exp Med; 2014; 23(6):877-84. PubMed ID: 25618112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacille Calmette-Guerin can induce cellular apoptosis of urothelial cancer directly through toll-like receptor 7 activation.
    Yu DS; Wu CL; Ping SY; Keng C; Shen KH
    Kaohsiung J Med Sci; 2015 Aug; 31(8):391-7. PubMed ID: 26228277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(I:C) potentiates Bacillus Calmette-Guérin immunotherapy for bladder cancer.
    Ayari C; Besançon M; Bergeron A; LaRue H; Bussières V; Fradet Y
    Cancer Immunol Immunother; 2016 Feb; 65(2):223-34. PubMed ID: 26759009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
    Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
    Molad Y; Pokroy-Shapira E; Carmon V
    Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial artesunate protects sepsis model mice against heat-killed Escherichia coli challenge by decreasing TLR4, TLR9 mRNA expressions and transcription factor NF-kappa B activation.
    Li B; Zhang R; Li J; Zhang L; Ding G; Luo P; He S; Dong Y; Jiang W; Lu Y; Cao H; Zheng J; Zhou H
    Int Immunopharmacol; 2008 Mar; 8(3):379-89. PubMed ID: 18279792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine protects mice from challenge with CpG ODN and LPS by decreasing proinflammatory cytokine release.
    Hong Z; Jiang Z; Liangxi W; Guofu D; Ping L; Yongling L; Wendong P; Minghai W
    Int Immunopharmacol; 2004 Feb; 4(2):223-34. PubMed ID: 14996414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired toll-like receptor 9 expression in alveolar macrophages with no sensitivity to CpG DNA.
    Suzuki K; Suda T; Naito T; Ide K; Chida K; Nakamura H
    Am J Respir Crit Care Med; 2005 Apr; 171(7):707-13. PubMed ID: 15640365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
    Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
    Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice.
    Lee TP; Huang JC; Liu CJ; Chen HJ; Chen YH; Tsai YT; Yang W; Sun KH
    Exp Biol Med (Maywood); 2014 Jun; 239(6):715-23. PubMed ID: 24719374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
    Ping SY; Wu CL; Yu DS
    Urol Oncol; 2012 Sep; 30(5):652-9. PubMed ID: 20884251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of bacillus Calmette-Guèrin and interferon alpha-2B on cytokine production in human bladder cancer cell lines.
    Zhang Y; Khoo HE; Esuvaranathan K
    J Urol; 1999 Mar; 161(3):977-83. PubMed ID: 10022737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Cells Derived from Human Breast Cancer Cells and Human Breast Epithelial Cells Exhibit Differential TLR4 and TLR9 Signaling.
    Tosun S; Fried S; Niggemann B; Zänker KS; Dittmar T
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A threshold level of TLR9 mRNA predicts cellular responsiveness to CpG-ODN in haematological and non-haematological tumour cell lines.
    Assaf A; Esteves H; Curnow SJ; Browning MJ
    Cell Immunol; 2009; 259(1):90-9. PubMed ID: 19573862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of TLR4-induced IL-6 response in bladder cancer cells by opposing actions of MAPK and PI3K signaling.
    Qian Y; Deng J; Xie H; Geng L; Zhou L; Wang Y; Yin S; Feng X; Zheng S
    J Cancer Res Clin Oncol; 2009 Mar; 135(3):379-86. PubMed ID: 18825409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.